Nifty
Sensex
:
:
22795.90
75311.06
-117.25 (-0.51%)
-424.90 (-0.56%)

Pharmaceuticals & Drugs - API

Rating :
N/A

BSE: 506235 | NSE: ALEMBICLTD

116.36
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  115.10
  •  118.87
  •  114.81
  •  113.21
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  284669
  •  330.84
  •  169.00
  •  78.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,585.79
  • 8.23
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,598.66
  • 2.38%
  • 1.14

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.88%
  • 0.85%
  • 21.75%
  • FII
  • DII
  • Others
  • 1.78%
  • 0.00%
  • 4.74%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 0.90
  • 16.33
  • 26.27

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 20.79
  • 78.48
  • 32.49

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.42
  • -0.03
  • 2.52

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.90
  • 9.18
  • 10.44

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.19
  • 1.18
  • 1.08

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 32.54
  • 35.11
  • 21.28

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
3.62
P/E Ratio
35.79
Revenue
144
EBITDA
56
Net Income
93
ROA
9.8
P/Bk Ratio
4.11
ROE
11.34
FCFF
13.23
FCFF Yield
0.4

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
57.92
39.32
47.30%
52.91
32.28
63.91%
50.78
36.84
37.84%
49.04
37.12
32.11%
Expenses
31.52
27.64
14.04%
33.34
22.13
50.66%
30.38
25.97
16.98%
24.89
23.67
5.15%
EBITDA
26.40
11.68
126.03%
19.57
10.15
92.81%
20.40
10.87
87.67%
24.15
13.45
79.55%
EBIDTM
45.58%
29.70%
36.99%
31.44%
40.17%
29.51%
49.25%
36.23%
Other Income
4.37
2.23
95.96%
65.61
47.87
37.06%
1.96
2.63
-25.48%
2.04
2.03
0.49%
Interest
0.69
0.37
86.49%
0.67
0.13
415.38%
0.49
0.13
276.92%
0.48
0.13
269.23%
Depreciation
2.69
2.66
1.13%
2.68
1.86
44.09%
2.50
1.83
36.61%
1.48
1.70
-12.94%
PBT
27.39
10.88
151.75%
81.83
56.03
46.05%
19.37
11.54
67.85%
24.23
3.04
697.04%
Tax
1.30
0.96
35.42%
4.52
4.32
4.63%
1.95
1.58
23.42%
2.94
-1.66
-
PAT
26.09
9.92
163.00%
77.31
51.71
49.51%
17.42
9.96
74.90%
21.29
4.70
352.98%
PATM
45.04%
25.23%
146.12%
160.19%
34.30%
27.04%
43.41%
12.66%
EPS
2.55
2.39
6.69%
4.71
3.53
33.43%
2.17
1.73
25.43%
2.81
1.88
49.47%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
210.65
157.49
127.24
78.22
73.52
73.93
123.81
125.30
147.16
127.53
143.95
Net Sales Growth
44.72%
23.77%
62.67%
6.39%
-0.55%
-40.29%
-1.19%
-14.85%
15.39%
-11.41%
 
Cost Of Goods Sold
25.50
48.95
41.12
22.62
22.24
12.17
54.07
78.50
96.33
69.67
74.09
Gross Profit
185.15
108.53
86.13
55.60
51.28
61.75
69.74
46.79
50.83
57.86
69.86
GP Margin
87.89%
68.91%
67.69%
71.08%
69.75%
83.52%
56.33%
37.34%
34.54%
45.37%
48.53%
Total Expenditure
120.13
100.62
86.91
64.29
63.09
70.79
105.74
114.22
140.45
121.53
135.35
Power & Fuel Cost
-
1.18
2.02
0.15
0.42
0.91
2.34
1.11
5.46
13.26
13.30
% Of Sales
-
0.75%
1.59%
0.19%
0.57%
1.23%
1.89%
0.89%
3.71%
10.40%
9.24%
Employee Cost
-
23.03
24.04
21.47
22.60
20.79
20.52
19.64
22.83
23.79
27.00
% Of Sales
-
14.62%
18.89%
27.45%
30.74%
28.12%
16.57%
15.67%
15.51%
18.65%
18.76%
Manufacturing Exp.
-
10.92
7.02
8.30
5.91
25.52
20.00
6.08
7.11
5.77
11.90
% Of Sales
-
6.93%
5.52%
10.61%
8.04%
34.52%
16.15%
4.85%
4.83%
4.52%
8.27%
General & Admin Exp.
-
11.85
8.90
9.12
6.63
8.30
7.15
6.80
6.48
5.30
4.66
% Of Sales
-
7.52%
6.99%
11.66%
9.02%
11.23%
5.77%
5.43%
4.40%
4.16%
3.24%
Selling & Distn. Exp.
-
2.19
1.90
0.69
0.92
0.87
0.11
0.34
0.90
2.11
2.88
% Of Sales
-
1.39%
1.49%
0.88%
1.25%
1.18%
0.09%
0.27%
0.61%
1.65%
2.00%
Miscellaneous Exp.
-
2.50
1.90
1.93
4.37
2.23
1.56
1.75
1.33
1.64
2.88
% Of Sales
-
1.59%
1.49%
2.47%
5.94%
3.02%
1.26%
1.40%
0.90%
1.29%
1.05%
EBITDA
90.52
56.87
40.33
13.93
10.43
3.14
18.07
11.08
6.71
6.00
8.60
EBITDA Margin
42.97%
36.11%
31.70%
17.81%
14.19%
4.25%
14.59%
8.84%
4.56%
4.70%
5.97%
Other Income
73.98
54.77
64.26
89.18
10.92
93.54
29.45
37.04
30.97
28.81
21.73
Interest
2.33
1.11
0.47
0.39
0.36
0.29
0.22
0.17
0.16
0.12
0.83
Depreciation
9.35
7.84
6.72
4.86
3.94
3.23
2.63
3.78
5.09
6.14
6.04
PBT
152.82
102.69
97.41
97.86
17.04
93.17
44.67
44.18
32.44
28.55
23.46
Tax
10.71
9.82
6.18
11.66
3.20
0.13
3.59
2.39
-0.86
0.61
-0.69
Tax Rate
7.01%
9.56%
7.12%
11.91%
18.78%
0.14%
8.04%
5.41%
-3.23%
2.41%
-2.94%
PAT
142.11
92.87
80.62
86.19
13.84
93.03
41.08
41.78
27.49
24.72
24.15
PAT before Minority Interest
142.11
92.87
80.62
86.19
13.84
93.03
41.08
41.78
27.49
24.72
24.15
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
67.46%
58.97%
63.36%
110.19%
18.82%
125.84%
33.18%
33.34%
18.68%
19.38%
16.78%
PAT Growth
86.28%
15.19%
-6.46%
522.76%
-85.12%
126.46%
-1.68%
51.98%
11.21%
2.36%
 
EPS
5.53
3.62
3.14
3.36
0.54
3.62
1.60
1.63
1.07
0.96
0.94

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
2,185.56
2,078.03
2,496.58
2,297.03
1,418.04
1,208.53
1,085.77
911.43
803.13
527.81
Share Capital
51.36
51.36
51.36
51.36
51.36
51.36
53.41
53.41
53.41
53.41
Total Reserves
2,134.21
2,026.68
2,445.23
2,245.67
1,366.69
1,157.17
1,032.37
858.02
749.72
474.40
Non-Current Liabilities
52.89
42.74
67.60
52.52
6.88
8.52
14.15
12.61
14.69
38.03
Secured Loans
7.39
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1.91
1.21
1.10
0.83
0.70
0.72
0.80
0.78
0.64
1.57
Current Liabilities
96.11
89.56
67.76
59.41
45.80
48.80
59.12
68.34
57.68
81.80
Trade Payables
31.02
17.38
19.27
17.81
12.99
24.75
16.42
14.76
16.36
19.19
Other Current Liabilities
33.09
45.05
35.54
30.67
22.07
8.07
31.82
39.20
27.37
26.22
Short Term Borrowings
0.00
0.00
0.00
0.28
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
31.99
27.13
12.96
10.66
10.74
15.97
10.89
14.38
13.95
36.39
Total Liabilities
2,334.56
2,210.33
2,631.94
2,408.96
1,470.72
1,265.85
1,159.04
992.38
875.50
647.64
Net Block
130.59
131.88
133.55
233.55
209.47
186.88
147.46
147.60
146.42
169.02
Gross Block
151.54
151.21
151.21
256.22
228.24
202.45
160.37
158.33
371.75
402.34
Accumulated Depreciation
20.95
19.33
17.66
22.67
18.78
15.57
12.92
10.73
225.34
233.33
Non Current Assets
2,191.38
2,032.45
2,488.63
2,306.87
1,307.90
1,167.08
972.32
801.10
706.29
458.23
Capital Work in Progress
1.10
0.13
0.19
37.27
18.69
22.26
31.64
0.16
0.00
2.47
Non Current Investment
1,774.65
1,708.16
2,182.01
2,030.58
1,078.88
957.76
792.85
651.28
558.62
286.52
Long Term Loans & Adv.
36.22
1.22
6.54
1.95
0.86
0.17
0.38
2.05
1.25
0.23
Other Non Current Assets
10.64
1.64
2.67
3.52
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
143.19
177.89
143.32
102.09
162.82
98.77
186.73
191.28
169.21
189.41
Current Investments
11.34
45.40
25.84
16.59
53.71
43.46
119.85
104.76
46.13
12.23
Inventories
92.60
88.61
86.87
54.28
35.41
35.33
32.41
50.61
74.90
84.31
Sundry Debtors
19.76
23.45
15.22
13.81
8.98
13.51
25.29
21.60
27.98
48.04
Cash & Bank
2.47
1.90
1.85
6.57
58.85
2.01
0.84
2.32
2.34
2.64
Other Current Assets
17.02
8.95
3.89
2.11
5.86
4.47
8.35
11.98
17.87
42.19
Short Term Loans & Adv.
13.10
9.57
9.65
8.73
4.38
2.59
6.34
9.88
16.24
42.19
Net Current Assets
47.08
88.32
75.56
42.68
117.03
49.97
127.61
122.94
111.53
107.61
Total Assets
2,334.57
2,210.34
2,631.95
2,408.96
1,470.72
1,265.85
1,159.05
992.38
875.50
647.64

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 10
Cash From Operating Activity
22.69
38.85
-17.75
-2.18
6.54
21.51
23.58
51.63
9.65
149.09
PBT
102.69
86.80
97.86
17.04
93.17
44.67
44.18
26.63
25.33
43.81
Adjustment
-42.09
-52.87
-78.66
1.65
-85.70
-20.51
-28.85
-20.86
-16.51
73.14
Changes in Working Capital
-38.47
11.44
-27.90
-18.64
0.60
1.99
11.89
46.06
1.70
36.16
Cash after chg. in Working capital
22.12
45.37
-8.70
0.05
8.06
26.15
27.22
51.83
10.52
153.11
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.57
-6.52
-9.04
-2.23
-1.53
-4.64
-3.64
-0.20
-0.87
-4.02
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
25.84
7.30
18.85
-34.87
56.72
71.67
-22.40
-46.69
-4.76
-23.50
Net Fixed Assets
-1.30
0.06
138.27
-42.74
-22.22
-32.70
-33.47
213.26
344.49
-27.30
Net Investments
92.03
223.30
-144.79
-383.89
7.99
70.53
-63.48
-62.37
-141.47
-0.04
Others
-64.89
-216.06
25.37
391.76
70.95
33.84
74.55
-197.58
-207.78
3.84
Cash from Financing Activity
-48.19
-46.39
-5.82
-15.36
-6.41
-92.01
-2.66
-4.96
-5.19
-118.15
Net Cash Inflow / Outflow
0.33
-0.24
-4.72
-52.41
56.85
1.17
-1.48
-0.02
-0.30
7.45
Opening Cash & Equivalents
0.93
1.17
5.89
58.30
2.01
0.84
2.32
2.34
2.64
16.41
Closing Cash & Equivalent
1.26
0.93
1.17
5.89
58.85
2.01
0.84
2.32
2.34
23.85

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
85.11
80.93
97.23
89.45
55.22
47.06
40.66
34.13
30.08
19.77
ROA
4.09%
3.33%
3.42%
0.71%
6.80%
3.39%
3.88%
2.94%
3.25%
2.88%
ROE
4.36%
3.52%
3.60%
0.75%
7.08%
3.58%
4.18%
3.21%
3.71%
5.58%
ROCE
4.86%
3.82%
4.10%
0.94%
7.12%
3.91%
4.44%
3.12%
3.82%
3.82%
Fixed Asset Turnover
1.04
0.84
0.52
0.30
0.34
0.68
0.80
0.58
0.35
0.27
Receivable days
50.07
55.47
67.74
56.58
55.52
57.19
67.34
59.14
103.47
293.96
Inventory Days
210.00
251.69
329.34
222.67
174.64
99.84
119.22
149.70
216.71
401.78
Payable days
180.44
162.67
299.17
252.73
120.48
74.61
55.73
40.49
60.75
331.66
Cash Conversion Cycle
79.64
144.48
97.90
26.52
109.68
82.42
130.83
168.35
259.43
364.08
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Cover
93.63
187.54
252.50
48.08
324.49
207.64
261.78
169.23
221.26
29.30

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.